How have predictors, moderators, mediators, treatment response, remission and resistance been defined and measured in randomised controlled trials for adolescent depression? A scoping review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
22 06 2020
Historique:
entrez: 24 6 2020
pubmed: 24 6 2020
medline: 16 2 2021
Statut: epublish

Résumé

Among randomised controlled trials for depressed adolescents, the extent of variation in how depressive symptom outcomes are defined is unknown. The variability in which potential predictors of these outcomes are tested is also unclear. This paper is a protocol describing the methods of a planned scoping review. The scoping review will examine and summarise how change in depressive symptoms have been described in RCT treatment studies to date. This review will report the measures used to describe change in depressive symptoms and whether the measure was used as a continuous or binary outcome or both. This review will describe how dichotomous outcome terms are defined to describe change in depression severity. This review will also examine predictors, moderators and mediators of change in depressive symptoms within RCTs. In this paper, we describe the protocol for our scoping review. Following the format outlined by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for scoping reviews, a research librarian will develop an operationalised search strategy, which we will apply to the MEDLINE, Embase, PsycINFO and Cumulative Index to Nursing and Allied Health Literature databases. We will search for papers from inception to 6 February 2020. A hand search for key citations will also be conducted. Investigator-raters will screen articles, first via the titles and abstracts and then through full-text reviews. We will include articles with randomised control design which assess the treatment of adolescents with major depressive disorder. We will systematically extract and synthesise prespecified data which includes: definition of depression used for participant inclusion, measures used to evaluate changes in depression, type of outcome used (continuous, binary or both), definitions of dichotomous terms to denote change in depression (eg, response, remission, recovery, etc) and reported predictors/moderators/mediators of change. Ethics approval is not required. Findings will be presented in journal publications and at conferences.

Identifiants

pubmed: 32571862
pii: bmjopen-2019-036171
doi: 10.1136/bmjopen-2019-036171
pmc: PMC7311009
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036171

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Can Acad Child Adolesc Psychiatry. 2019 Nov;28(3):115-133
pubmed: 31798650
NCHS Data Brief. 2019 Oct;(352):1-8
pubmed: 31751202
J Rheumatol. 2014 May;41(5):986-93
pubmed: 24584917
J Am Acad Child Adolesc Psychiatry. 2019 Jul;58(7):656-658
pubmed: 31229181
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):160-166
pubmed: 26862813
Lancet. 2016 Aug 27;388(10047):881-90
pubmed: 27289172
JAMA. 2004 Aug 18;292(7):807-20
pubmed: 15315995
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Health Serv Res Policy. 2012 Jan;17(1):1-2
pubmed: 22294719
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
PLoS Med. 2008 Apr 29;5(4):e96
pubmed: 18447577
Health Technol Assess. 2008 May;12(14):iii-iv, ix-60
pubmed: 18462573
Healthc Policy. 2006 Nov;2(2):76-89
pubmed: 19305706
J Clin Child Adolesc Psychol. 2017 Jan-Feb;46(1):11-43
pubmed: 27870579
Arch Gen Psychiatry. 2002 Oct;59(10):877-83
pubmed: 12365874
Depress Anxiety. 2011 Nov;28(11):946-54
pubmed: 21898710
J Am Acad Child Adolesc Psychiatry. 2019 Jan;58(1):61-71
pubmed: 30577940
J Affect Disord. 2008 Jan;105(1-3):221-8
pubmed: 17568682
Lancet Psychiatry. 2019 Sep;6(9):735-744
pubmed: 31371212
Depress Anxiety. 2018 Aug;35(8):700-716
pubmed: 29878410
PLoS One. 2016 Dec 14;11(12):e0168403
pubmed: 27973622
Pediatrics. 2016 Dec;138(6):
pubmed: 27940701
BMC Med Res Methodol. 2016 Feb 09;16:15
pubmed: 26857112

Auteurs

Darren Courtney (D)

Child, Youth and Family Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada dr.courtney.research@gmail.com.
Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Priya Watson (P)

Child, Youth and Family Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Benjamin W C Chan (BWC)

Toronto, Ontario, Canada.

Kathryn J Bennett (KJ)

Health Research Methods, Evidence and Impact (formerly Clinical Epidemiology and Biostatistics), McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.

Kirsten Neprily (K)

Psychology, University of Calgary, Calgary, Alberta, Canada.

Tabitha Zentner (T)

Child, Youth and Family Services, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Terri Rodak (T)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Renira Narrandes (R)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Peter Szatmari (P)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH